B+
Bull case
20%
Probability
Target price
$25.96
+73.9% vs current
SDGR
SchrodingerBNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-03
AI scenario view
RankAlpha Sentiment AIMost likely
B
Base case
60%
Probability
Target price
$24.67
+65.2% vs current
B-
Bear case
20%
Probability
Target price
$9.00
-39.7% vs current
AI sentiment snapshot
Latest data as of 2026-02-26
Recent news sentiment (30D)
-26.5
Negative
Company
-
Unavailable
Macro
-26.5
Negative
Pulse
-
Unavailable
Sentiment proxy
+92.7
Score
AI commentary
Market sentiment shows wide dispersion in analyst views with an elevated median but a large high/low spread reflecting differing views on commercialization [#SERP-2]. Some outlets report low targets near $9, underscoring downside scenarios tied to adoption and execution risk [#SERP-1]. Consensus aggregates skew toward growth expectations but with notable volatility and mixed ratings across sources [#SERP-4].
RankAlpha Sentiment AI - 2026-02-26
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-05-27catalystUpcoming quarterly results and guidanceHigh impact
Near-term quarterly release could drive re-rating on beats or missed guidance; timing conservative set at 90 days post as_of_date [#SERP-1].
2026-08-31eventPotential partnership or licensing announcementHigh impact
A material pharma collaboration or license would expand recurring revenue and could sharply re-rate shares; date assumed as window end where no firm date disclosed [#SERP-4].
2027-02-26catalystCommercial adoption and platform monetizationHigh impact
Sustained revenue growth from software and discovery services over the next year could re-rate shares if adoption accelerates and converts pipeline to recurring revenue [#SERP-2].
Recommendation
N/A
No formal recommendation provided.
As of 2026-02-26 • Updated nightlySource: Internal modelMethodology